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ABSTRACT 
 
Background: Leishmaniasis is vector borne disease caused by  protozoa.Visceral Leishmaniasis is a major public 
health problem in Nepal. Different manifestations in otorhinolaryngology includes nasal bleeding, granulomatous 
mass mucosal ulceration in oral cavity. polypoidal growth in larynx, chronic non- healing painless ulcer, nodule ,  
sensorineural deafness . 
Methods: This is a prospective cross sectional study where eighty diagnosed cases of leishmaniasis were included 
from January 2007 to January 2008. Diagnosis was made by Rk-39 from peripheral smear & LD bodies from bone 
marrow.  Before starting anti –kalaazar treatment, ENT examination and Pure tone audiometry (Amplaid 460, Italian 
machine) was done and finding noted.  
Results:  Visceral leismaniasis occur from age 4 yr to 70 yr. Otolaryngological manifestations found in 47 % of cases. 
Among them epistaxis was observed in 19 (24%) cases. Hearing loss had 8 (10%) of cases. Laryngeal Leishmaniasis 
was seen in one patient. Mortality was seen in one patient.  
Conclusion: Otolaryngological manifestation of Visceral Leishmaniasis is not uncommon in the patients belonging 
to endemic area like ours. Epistaxis & hearing loss are common.  
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Background  
 
Leishmaniasis refers to the spectrum of disease caused by Leishmania Species, which are protozoa of order 
kinetoplasitida.  Clinically Leishmaniasis is divided into three: Visceral (kala-azar), cutaneous and mucosal 
syndromes. Kala-azar is most commonly caused by L. donovani, L. infantum and L. chagasi.  
 Visceral Leishmaniasis (VL) is a major public health problem in Nepal. The disease is endemic in twelve 
terai districts of eastern and southern Nepal. It is estimated that more than 6 million people in Nepal are at risk of 
leishmania infection. 
 Different otorhinolaryngological manifestation is seen in Leishmaniasis Chronic non-healing painless 
ulcer, nodule, papule, impetignoid lesion, lupoid lesion are seen in face. In nose, serous and crusted rhinorrhoea, 
nasal obstruction, ulceration, granulomatous lesion, masses and septal perforation are seen. 
 Mucosal ulceration, whitish red nodular swelling, mass may present in oral cavity and oropharynx. 
Hoarseness of voice, Polypoidal growths in larynx may occur. There may be regional lymphadenitis and in 
untreated cases death follows from exhaustation. 
 Neurologic changes in VL are rarely reported. Burning feet, foot drop, deafness and multiple cranial 
nerves palsies may occur due to axonal degeneration and demyelination.  Deafness is sensory-neural type and 
hearing may returned to normal after treatment with sodium stibogluconate. 
 Nepal is ecologically divided into 3 distinct regions: mountain in the north, hilly region in between and the 
plains (Terai) in the south, bordering India. In the latter, a sub-tropical climate prevails, and it is affected by 
several tropical diseases. B.P. koirala Institute of Health Sciences (BPKIHS) is a health sciences university, 
situated in Dharan, Sunsari district, in the Terai region. Its 640-bed teaching hospital serves as a referral hospital 
for the eastern region of Nepal, and the tropical disease unit is known to the inhabitants of Terai as a specialized 
kala-azar centre providing free treatment to kala-azar patients. It also attracts a major part of the VL patients from 
the neighboring districts. Patients usually tend to seek care at BPKIHS after traditional healers or private 
practitioners have failed to cure their symptoms. Several others consult directly without going to the first line 
public health facilities. 
 In spite of the various otorhinolarygologcal manifestations cited above, and such burden of kala-azar in 
eastern  terai  area of Nepal , no definite study about otorhinolaryngological menifestation has been done till date.  
 
Greener Journal of Medical Sciences                         ISSN: 2276-7797                             Vol. 2 (6), pp. 134-136, November 2012. 
 
  www.gjournal.org                                                                                 135 
 
Hence considering the above facts, a study was taken up to find out the various otolaryngological manifestation 
of Visceral Leishmaniasis. 
 
MATERIALS AND METHODS 
 
This study was  conducted at Department of Otorhinolaryngology and Head & Neck Surgery, and Department of 
Internal Medicine in B. P. Koirala Institute of Health Sciences Dharan, Nepal over period of one year from 
January 2007 to January 2008. It was hospital based Prospective cross sectional study. Ethical approval will be 
obtained from the ethical committee and Informed consent will be taken from participants prior to the study. 
 Patient was first evaluated in the Department of Internal Medicine with clinical history, clinical 
examination and routine laboratory investigation for the diagnosis. Diagnosis of   VL was made by Rk-39 from 
peripheral smear & LD bodies from   bone marrow or tissue biopsy. Patient already on anti VL treatment, any 
other established condition /co-morbidities giving rise to similar manifestation, not willing to participate in the 
study were excluded from the study. Diagnosed eighty cases were subjected to ear,nose and throat evaluation.  
Findings were noted.  No major, active interventions will be carried out other than those required regarding 
disease evaluation and disease management. 
 All patients were assessed with pure tone Audiometry (PTA).
 
Air and bone conduction hearing levels was 
measured by means of pure tone audiometer (Amplaid 460, Italian machine) by a single audiometrician in 
500Hz,1000Hz,20000Hz,4000Hz, & 8000Hz. Hearing status was confirmed on the basis of WHO Classification 
Other appropriate diagnostic test was done as necessary.  Data analysis done by SPSS 12.0 version. 
 
 
RESULT 
 
This study included a total of 80 diagnosed cases of visceral leishmaniasis age ranging from 4-70 years and 
mean age 29.8±15.1 years. 52 (65%) cases were males. Male to female ratio was 1.85:1.(Table 1) 
 
Table 1. Gender distribution 
 
                 Gender                                        No. of  cases                      % 
                   Male                                               52                                 65 
Female 28                                 35 
Total  80                               100 
 
 
 Nasal bleeding was most common manifestation, which was found in 19(24%) cases. Hearing loss was 
2nd most common by 8(10%) of cases. Oral presentations were sore throat in 3 cases & gum bleeding in 2 cases. 
One case presented with right neck hematoma which was died due to severe bleeding. Two patients had 
laryngeal manifestation, of them one had laryngitis and other had laryngeal mass which presented with stridor. 
(Table 2) 
 
Table 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ENT Symptoms/sign No of cases (%)  
Episaxis 
 Hearing loss 
19 
8 
24 
10 
Sore throat 3  4 
 Gum bleed 
macule 
2 
2 
3 
3 
 stridor 1 1 
 laryngitis 
 Hematoma  of neck 
1 
1 
1 
1 
Total 37 47 
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Unilateral bleeding was seen in 11(58%) cases, whereas bilateral bleeding was seen in 8(42%) of cases.(Table 
3) 
 
 
Table 3. Site of Epistaxis 
 
laterality No.  of cases Percent (%) 
Unilateral nostril 
Bilateral nostril 
Total 
11 
 8 
19 
58 
42 
100   
 
 
       During Pure Tone Audiometry evaluation, 34 (43%) cases had sensorineural type of hearing loss. (Table 4)  
 
Table 4.Pure tone audiometry finding 
 
Finding No.  of cases Percent (%) 
Normal 
SNHL 
46 
34 
57 
43 
Total 80 100 
 
 
 
DISCUSSION 
 
Leishmaniasis is caused by infection with parasites of the genus Leishmania. Leishmaniasis is not a single 
disease but a ‘variety of syndromes’ that are complex and cosmopolition. Visceral Leishmaniasis caused by L. 
Donovani which is endemic in eastern terai of Nepal.10 Of 80 cases,  (65%) cases were males. Male to female 
ratio was 1.85:1.   Male were predominant than women. Similar finding was observed in other study from Nepal 
and Bangladesh. Male predominant may be due to male dominance society of Nepal, more health care given to 
male child than female and male seek hospital earlier than female. 
 Prevalence of epistaxis in Visceral leishmaniasis patient around 47-88%. In our study value was only 
24%. It may be due to the fact that our study included    patients admitted only in BPKIHS. Bilateral bleeding 
occur in 11 (58%) of cases while unilateral in 8 (42%). There was no specific pattern of bleeding as most of the 
cases had diffuse mucosal bleed. The pathogenesis of Epistaxis occurring in early phase of disease, is not 
understood; but occurring late in the disease is probably due to a combination of deficient clotting factor and 
thrombocytopenia Pure tone  Audiometry  showed 34 (43%)  had  senosrineural hearing loss  in this study,  
though 4.5% patient  had sensorineural deafenss.  Variation of result could be due the fact that Audiometry was 
done routinely in all patients even without complain of hearing loss. 
 One 23/M   had neck hematoma with nasal  bleeding. Incision and drainage was done for neck 
hematoma. In spite of blood transfusion, patient died due to excessive uncontrollable bleeding.  
 Two patients presented with laryngeal symptoms. One had laryngitits who later improved after 
medication. Other 70/M presented had hoarseness for 3 months & noisy respiration for 5 days. Emergency 
Tracheostomy was done to relieve stridor. DL biopsy was inconclusive twice. Endoscopic biopsy Showed 
granulation tissue with lymphocytic infiltrates and numerous LD bodies. Patient improved with Amphotericin B. 
This was the first case of laryngeal leishmaniasis reported from Nepal in our Knowledge.  A case of Primary 
laryngeal leishmaniasis reported from Italy in 1964 and india in 2007. 
 
 
CONCLUSION 
 
Otorhinolaryngological manifestation of Visceral Leishmaniasis is not uncommon in the patients belonging to 
endemic area like ours.  Epistaxis & hearing loss are common presentations. Further studies with larger series of 
case and follow up need to be taken into consideration. 
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